ZA875183B - Fused benzazepines - Google Patents

Fused benzazepines

Info

Publication number
ZA875183B
ZA875183B ZA875183A ZA875183A ZA875183B ZA 875183 B ZA875183 B ZA 875183B ZA 875183 A ZA875183 A ZA 875183A ZA 875183 A ZA875183 A ZA 875183A ZA 875183 B ZA875183 B ZA 875183B
Authority
ZA
South Africa
Prior art keywords
benzazepines
useful
fused benzazepines
fused
hypertension
Prior art date
Application number
ZA875183A
Other languages
English (en)
Inventor
Gilbert Berger Joel
Kong Chang Wei
Herman Gold Elijah
Welch Clader John
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of ZA875183B publication Critical patent/ZA875183B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/32—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Luminescent Compositions (AREA)
ZA875183A 1987-07-15 1987-07-15 Fused benzazepines ZA875183B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001636 WO1989000561A1 (en) 1987-07-15 1987-07-15 Fused benzazepines
EP87110253A EP0299101B1 (de) 1987-07-15 1987-07-16 Kondensierte Benzazepine

Publications (1)

Publication Number Publication Date
ZA875183B true ZA875183B (en) 1988-04-08

Family

ID=26108265

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA875183A ZA875183B (en) 1987-07-15 1987-07-15 Fused benzazepines

Country Status (13)

Country Link
EP (2) EP0363353B1 (de)
JP (1) JPH0678317B2 (de)
AT (1) ATE78467T1 (de)
AU (1) AU617651B2 (de)
DE (1) DE3780649T2 (de)
DK (1) DK162889C (de)
ES (1) ES2043623T3 (de)
FI (1) FI93212C (de)
GR (1) GR3006671T3 (de)
HU (1) HU203537B (de)
NO (1) NO177264C (de)
WO (1) WO1989000561A1 (de)
ZA (1) ZA875183B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
PL168408B1 (pl) * 1989-08-03 1996-02-29 Smithkline Beecham Biolog Sposób wytwarzania stransformowanego mikroorganizmu PL
ATE126511T1 (de) * 1990-02-02 1995-09-15 Schering Corp 4,5-cycloalkano-3-benzazepin-7-ol-derivate und ihre verwendung.
JPH07137816A (ja) * 1993-11-15 1995-05-30 Tokai Univ 地下空洞内貯蔵装置
JP4555685B2 (ja) * 2002-08-29 2010-10-06 シェーリング コーポレイション 肥満およびｃｎｓ障害の処置のための選択的ｄ１／ｄ５レセプターアンタゴニスト
CN1823059A (zh) * 2003-05-22 2006-08-23 先灵公司 作为治疗肥胖和CNS疾病的选择性D<sub>1</sub>/D<sub>5</sub>受体拮抗剂的5－H－苯并[D]萘并[2,1－B]氮杂䓬衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
JPH0681745B2 (ja) * 1986-01-16 1994-10-19 シェリング・コ−ポレ−ション 縮合ベンゾアゼピン

Also Published As

Publication number Publication date
DK9390D0 (da) 1990-01-12
DK162889B (da) 1991-12-23
ATE78467T1 (de) 1992-08-15
EP0363353A1 (de) 1990-04-18
NO900186L (no) 1990-01-12
DE3780649D1 (de) 1992-08-27
FI900175A0 (fi) 1990-01-12
GR3006671T3 (de) 1993-06-30
EP0363353B1 (de) 1992-07-22
FI93212B (fi) 1994-11-30
JPH0678317B2 (ja) 1994-10-05
EP0299101B1 (de) 1992-09-23
HU203537B (en) 1991-08-28
DE3780649T2 (de) 1992-12-10
NO900186D0 (no) 1990-01-12
FI93212C (fi) 1995-03-10
DK9390A (da) 1990-03-12
DK162889C (da) 1992-05-11
JPH02504629A (ja) 1990-12-27
NO177264B (no) 1995-05-08
NO177264C (no) 1995-08-16
ES2043623T3 (es) 1994-01-01
EP0299101A1 (de) 1989-01-18
AU617651B2 (en) 1991-12-05
WO1989000561A1 (en) 1989-01-26
AU8037887A (en) 1989-02-13

Similar Documents

Publication Publication Date Title
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
HUT49592A (en) Process for producing bis/hydroxymethyl/-cyclobutyl-purines and pyrimidines, as well as pharmaceutical compositions comprising same
AU7467187A (en) Injectable implant composition having improved intrudability
ZA949584B (en) Preparation of 3, 4, 4-trisubstituted piperidinyl-N-alkyl-carboxylates and intermediates
JPS6413076A (en) Novel compound, manufacture and medicinal composition
GR3036816T3 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
WO1987004430A3 (en) Fused benzazepines
JPS6426578A (en) 2,2-dimethylchroman-3-ol derivative, manufacture and drug composition
DK166685A (da) Fremgangsmaade til fremstilling af cellulolytiske enzymer og fremgangsmaade til forsukring af cellulosematerialer dermed
OA08608A (en) Pestical compositions and process for preparation thereof.
JPS6470458A (en) Alkylaminoalkoxyphenyl derivative, manufacture and composition
PT80752B (pt) Processo de preparacao de composicoes farmaceuticas solidas contendo di-hidropiridinas
HUT54888A (en) Process for producing stabile, liofilized polyhaematoporfirin-aether and -ester compositions and pharmaceutical compositions containing them
GR3006671T3 (de)
GR3034739T3 (en) 2-Aryl-5-trifluoromethyl)-2-pyrroline compounds and process for the manufacture of insecticidal, 2-aryl-1-(alkoxymethyl)-4-halo-5-(trofluoromethyl) pyrroles.
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
IL74138A0 (en) Indolophenanthridines,their production and pharmaceutical compositions containing them
HUT37887A (en) Disinfecting compositions and process for the preparation thereof
MY129947A (en) Novel substituted thienopyrans as antihypertensive agents.
JPS6480287A (en) Novel compound, method for manufacture of the same and drug composition containing the same
DE3562613D1 (en) 4-(2,2,3-trimethylcyclopent-3-en-1-yl)-but-3-en-1-ols, process for their preparation and use as fragrance compounds
HUT75457A (en) Spayable antihypertensive composition and process for it`s production
HUT40648A (en) Process for producing optically active substituted 1,4-dihydro-pyridines and pharmaceutical compositions containing them as active agents
AU7054287A (en) Disinfecting composition
DE69425405D1 (de) Verbessertes Verfahren zur Herstellung von 2,4-di(alkylamine)-6-alkylthio-s-Triazinen und 2,4-alkylamine-4,6-di(alkylthio)-s-Triazinen